Pediatric Iatrogenic Movement Disorders

Gu Q, Dillon CF, and Burt VL: Prescription Drug Use Continues to Increase: U.S. Prescription Drug Data for 2007–2008. NCHS Data Brief, No. 42. (DHHS Publication No. [PHS] 2010-1209). September 2010 van Gaalen, 2014, Drug-Induced cerebellar ataxia: A systematic review, CNS Drugs, 28, 1139, 10.1007/s40263-014-0200-4 Lazarus, 1981, Central nervous system toxicity of high-dose systemic cytosine arabinoside, Cancer., 48, 2577, 10.1002/1097-0142(19811215)48:12<2577::AID-CNCR2820481207>3.0.CO;2-Z Variava, 2017, Brief report: Late efavirenz-induced ataxia and encephalopathy: A case series, J Acquir Immune Defic Syndr, 75, 577, 10.1097/QAI.0000000000001451 Paul, 2016, Adverse events associated with pediatric exposures to dextromethorphan, Clin Toxicol, 55, 25, 10.1080/15563650.2016.1240803 Gilbert, 2009, Acute and chronic chorea in childhood. Seminars in, Pediatr Neurol, 16, 71, 10.1016/j.spen.2009.03.009 Singer, 2016 2005, Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity, Arch Gen Psychiatry, 62, 1266, 10.1001/archpsyc.62.11.1266 Mostofsky, 2003, Overflow movements predict impaired response inhibition in children with ADHD, Percept Mot Skills, 97, 1315, 10.2466/pms.2003.97.3f.1315 Filloux, 1987, Transient chorea induced by phenytoin, J Pediatr, 110, 639, 10.1016/S0022-3476(87)80570-X Shulman, 1996, Phenvtoin-induced focal chorea, Mov Disord., 11, 111, 10.1002/mds.870110128 Otárula, 2016, Phenytoin-induced chorea, Clin Neuropharmacol, 39, 120, 10.1097/WNF.0000000000000140 Bimpong-Buta, 1982, Carbamazepine-induced choreoathetoid dyskinesias, J Neurol Neurosurg Psychiatry, 45, 560, 10.1136/jnnp.45.6.560 Gunal, 2002, Reversible valproate-induced choreiform movements, Seizure, 11, 205, 10.1053/seiz.2001.0576 Srinivasan, 2010, Valproate-induced reversible hemichorea, Mov Disord, 25, 1511, 10.1002/mds.23119 Zesiewicz, 2006, Chorea induced by lamotrigine, J Child Neurol, 21, 357, 10.1177/08830738060210041301 Attupurath, 2009, Chorea associated with gabapentin use in an elderly man, Am J Geriatr Pharmacother, 7, 220, 10.1016/j.amjopharm.2009.08.001 Plas, 2010, Baclofen-induced chorea in complex regional pain syndrome-related dystonia, Mov Disord., 25, 959, 10.1002/mds.23035 Weiner, 1978, Methylphenidate-induced chorea: Case report and pharmacologic implications, Neurology, 28, 1041, 10.1212/WNL.28.10.1041 Morgan, 2004, Amphetamine-induced chorea in attention deficit-hyperactivity disorder, Mov Disord., 19, 840, 10.1002/mds.20081 Morgan, 2004, Amphetamine-induced chorea in attention deficit-hyperactivity disorder, Mov Disord, 19, 840, 10.1002/mds.20081 Klawans, 1974, The effect of d-amphetamine on choreiform movement disorders, Neurology, 24, 312, 10.1212/WNL.24.4.312 Hollister, 1957, Complications from the use of tranquilizing drugs, N Engl J Med, 257, 170, 10.1056/NEJM195707252570405 Pomponi, 2011, P03-104—Use of atypical antipsychotics and movement disorders: a case of aripiprazole induced chorea, Eur Psychiatry., 26, 1273, 10.1016/S0924-9338(11)72978-9 Podskalny, 1996, Chorea caused by lithium intoxication: A case report and literature review, Mov Disord., 11, 733, 10.1002/mds.870110623 Marsden, 1981, Fluctuations of disability in Parkinsons disease—Clinical aspects, Mov Disord, 96, 10.1016/B978-0-407-02295-9.50012-6 Lieberman, 1981, Treatment of advanced Parkinsons disease with dopamine agonists, Mov Disord, 146, 10.1016/B978-0-407-02295-9.50014-X Antelmi, 2015, Persistent chorea in DYT6, due to anticholinergic therapy, Parkinsonism Relat Disord, 21, 1282, 10.1016/j.parkreldis.2015.07.024 Nomoto, 1987, Anticholinergic-induced chorea in the treatment of focal dystonia, Mov Disord., 2, 53, 10.1002/mds.870020107 Mendelson, 1977, Pheniramine aminosalicylate overdosage. Reversal of delirium and choreiform movements with tacrine treatment, Arch Neurol, 34, 313, 10.1001/archneur.1977.00500170067014 Klawans, 1977, Cyclizine-induced chorea: Observations on the influence of cyclizine on dopamine-related movement disorders, J Neurol Sci, 31, 237, 10.1016/0022-510X(77)90109-5 Samie, 1989, Choreoathetosis induced by cyproheptadine, Mov Disord, 4, 81, 10.1002/mds.870040111 Fann, 1976, Dyskinesias associated with tricyclic antidepressants, Br J Psychiatry, 128, 490, 10.1192/bjp.128.5.490 Bharucha, 1996, Complex movement disorders induced by fluoxetine, Mov Disord., 11, 324, 10.1002/mds.870110318 Azar, 2005, Ciprofloxacin-induced chorea, Mov Disord., 20, 513, 10.1002/mds.20425 Farooq, 2011, Azithromycin-induced agitation and choreoathetosis, Pediatr Neurol, 44, 311, 10.1016/j.pediatrneurol.2010.11.014 Greenhouse, 1966, On chorea, lupus erythematosus, and cerebral arteritis, Arch Intern Med, 117, 389, 10.1001/archinte.1966.03870090073012 Nausieda, 1980, Chorea induced by oral contraceptives, Neurology, 30, 1131, 10.1212/WNL.30.10.1131-a Tilzey, 1981, Toxic confusional state and choreiform movements after treatment with anabolic steroids, Br Med J, 283, 349, 10.1136/bmj.283.6287.349-a Isaacs, 2005, Chorea associated with thyroxine replacement therapy, Mov Disord., 20, 1656, 10.1002/mds.20603 Kondziella, 2009, Choreathetosis due to abuse of levothyroxine, J Neurol, 256, 2106, 10.1007/s00415-009-5314-0 Wasserman, 1980, Choreic movements induced by the use of methadone, Arch Neurol, 37, 727, 10.1001/archneur.1980.00500600075016 Örken, 2009, Intrathecal methotrexate-induced acute chorea, J Pediatr Hematol Oncol, 31, 57, 10.1097/MPH.0b013e318190d434 Plas, 2010, Digoxin-induced chorea in a child, Mov Disord., 25, 959 Tison, 1991, Delayed onset movement disorders as a complication of central pontine myelinolysis, Mov Disord, 6, 171, 10.1002/mds.870060215 Maraganore, 1992, Movement disorders as sequelae of central pontine myelinolysis: Report of three cases, Mov Disord, 7, 142, 10.1002/mds.870070208 Rana, 2012, Chorea and seizures in iatrogenic hypocalcaemia caused by accidental parathyroidectomy, Br J Hosp Med, 73, 470, 10.12968/hmed.2012.73.8.470 Baizabal-Carvallo, 2016, Movement disorders induced by deep brain stimulation, Parkinsonism Relat Disord, 25, 1, 10.1016/j.parkreldis.2016.01.014 Zuccarelli, 2016, Hemiballismus as a complication of an intratumoral chemotherapy catheter, J Clin Neurosci, 30, 129, 10.1016/j.jocn.2016.01.031 Wonodi, 2007, Tardive dyskinesia in children treated with atypical antipsychotic medications, Mov Disord., 22, 1777, 10.1002/mds.21618 Medication-Induced Movement Disorders and Other Adverse Effects of Medication. Diagnostic and Statistical Manual of Mental Disorders, 5th Ed. 2013 Aquino, 2014, Tardive dyskinesia syndromes: Current concepts, Parkinsonism Relat Disord, 20, S113, 10.1016/S1353-8020(13)70028-2 Wijemanne, 2015, Movement disorders from the use of metoclopramide and other antiemetics in the treatment of migraine, Headache, 56, 153, 10.1111/head.12712 Waln, 2013, An update on tardive dyskinesia: From phenomenology to treatment, Tremor Other Hyperkinet Mov, 3, 10.5334/tohm.165 Mejia, 2010, Tardive dyskinesia and withdrawal emergent syndrome in children. Expert review of neurotherapeutics, 10, 893 Hussar, 2017, Ocrelizumab, edaravone, and valbenazine, J Am Pharm Assoc, 57, 551, 10.1016/j.japh.2017.06.008 Citrome, 2017, Valbenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?, Int J Clin Pract, 71 Marks, 2009, Deep brain stimulation for pediatric movement disorders. Seminars in, Pediatr Neurol, 16, 90, 10.1016/j.spen.2009.04.001 Voon, 2017, Impulse control disorders and levodopa-induced dyskinesias in Parkinsons disease: An update, Lancet Neurol, 16, 238, 10.1016/S1474-4422(17)30004-2 Pons, 2013, Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency, Mov Disord., 28, 1058, 10.1002/mds.25382 Mehta, 2015, Drug-induced movement disorders, Neurol Clin, 33, 153, 10.1016/j.ncl.2014.09.011 Neale, 1983, Effects of dopamine agonists, catecholamine depletors, and cholinergic and GABAergic drugs on acute dyskinesias in squirrel monkeys, Psychopharmacology (Berl), 82, 20, 10.1007/BF00426374 Jiménez-Jiménez, 2004, Drug-induced myoclonus: Frequency, mechanisms and management, CNS Drugs, 18, 93, 10.2165/00023210-200418020-00003 Janssen, 2016, The clinical heterogeneity of drug-induced myoclonus: An illustrated review, J Neurol, 264, 1559, 10.1007/s00415-016-8357-z Ford, 1997, Spinal myoclonus induced by an intrathecal catheter, Mov Disord., 12, 1042, 10.1002/mds.870120632 Glavina, 1988, Myoclonic spasms following intrathecal morphine, Anaesthesia, 43, 389, 10.1111/j.1365-2044.1988.tb09020.x Holdcroft, 1976, Effect of dose and premedication on induction complications with etomidate, Br J Anaesth, 48, 199, 10.1093/bja/48.3.199 Du, 2017, Effect of dexmedetomidine in preventing etomidate-induced myoclonus: A meta-analysis, Drug Des Devel Ther, 11, 365, 10.2147/DDDT.S121979 Denckla, 1976, Tics following methylphenidate administration, J Am Med Assoc, 235, 1349, 10.1001/jama.1976.03260390035024 Varley, 2001, Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications, Compr Psychiatry, 42, 228, 10.1053/comp.2001.23145 Müller-Vahl, 2017, Gilles de la Tourette syndrome is associated with hypermethylation of the dopamine D2 receptor gene, J Psychiatr Res, 86, 1, 10.1016/j.jpsychires.2016.11.004 Ledbetter, 2005, Atomoxetine use associated with onset of a motor tic, J Child Adolesc Psychopharmacol, 15, 331, 10.1089/cap.2005.15.331 Párraga, 2007, Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder, Int J Psychiatry Med, 37, 415, 10.2190/PM.37.4.e Spencer, 1993, Case study: Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette’s syndrome, J Am Acad Child Adolesc Psychiatry, 32, 211, 10.1097/00004583-199301000-00030 Sears, 2008, Development of tics in a thirteen-year-old male following atomoxetine use, CNS Spectr, 13, 301, 10.1017/S1092852900016412 Neglia, 1984, Tics and vocalizations in children treated with carbamazepine, Pediatrics, 73, 841, 10.1542/peds.73.6.841 Kurlan, 1989, Carbamazepine-induced tics, Clin Neuropharmacol, 12, 298, 10.1097/00002826-198908000-00007 Robertson, 1993, Carbamazepine-induced tics, Epilepsia, 34, 965, 10.1111/j.1528-1157.1993.tb02119.x Sotero de Menezes, 2000, Lamotrigine-induced tic disorder: Report of five pediatric cases, Epilepsia, 41, 862, 10.1111/j.1528-1157.2000.tb00254.x Magaudda, 2012, Carbamazepine-induced non-epileptic myoclonus and tic-like movements, Epileptic Disord, 14, 172, 10.1684/epd.2012.0504 Chandran, 2017, Dystonic tics induced by deep brain stimulation of the posterior subthalamic area for essential tremor, J Neurosurg, 126, 386, 10.3171/2015.12.JNS15915 Karas, 1982, Valproate tremors, Neurology, 32, 428, 10.1212/WNL.32.4.428 Karas, 1983, Treatment of valproate tremors, Neurology, 33, 1380, 10.1212/WNL.33.10.1380 Lancman, 1994, Acetazolamide appears effective in the management of valproate-induced tremor, Mov Disord., 9, 369, 10.1002/mds.870090321 Klerman, 1965, Clinical pharmacology of imipramine and related antidepressant compounds, Pharmacol Rev, 17, 101 Kronfol, 1983, Imipramine-induced tremor: Effects of a beta-adrenergic blocking agent, J Clin Psychiatry, 44, 225 Baek, 2013, Lithium tremor revisited: Pathophysiology and treatment, Acta Psychiatr Scand, 129, 17, 10.1111/acps.12171 Donaldson, 1983, Persisting neurologic sequelae of lithium carbonate therapy, Arch Neurol, 40, 747, 10.1001/archneur.1983.04050110065011 Schaffler, 1987, Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol, Int J Clin Pharmacol Ther Toxicol, 25, 673 Simons, 1981, Dose response of subcutaneous terbutaline and epinephrine in children with acute asthma, Arch Pediatr Adolesc Med, 135, 214, 10.1001/archpedi.1981.02130270006004 Gadomski, 1992, The need for rational therapeutics in the use of cough and cold medicine in infants, Pediatrics, 89, 774, 10.1542/peds.89.4.774 Koller, 1987, Caffeine and tremor, Neurology, 37, 169, 10.1212/WNL.37.1.169 Deuschl, 1998, Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee, Mov Disord., 13, 2, 10.1002/mds.870131303 Conget, 1989, Widespread tremor after injection of sodium calcitonin, Br Med J, 298, 189, 10.1136/bmj.298.6667.189-a Smith, 1970, Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism, Br Med J, 4, 145, 10.1136/bmj.4.5728.145 Charness, 1984, Frequent neurologic toxicity associated with amiodarone therapy, Neurology, 34, 669, 10.1212/WNL.34.5.669 Manolis, 1990, Mexiletine: Pharmacology and therapeutic use, Clin Cardiol, 13, 349, 10.1002/clc.4960130509 Rubinstein, 1986, Tremor induced by procainamide, Am J Cardiol, 57, 340, 10.1016/0002-9149(86)90917-3 Bechstein, 2000, Neurotoxicity of calcineurin inhibitors: Impact and clinical management, Transpl Int, 13, 313, 10.1111/j.1432-2277.2000.tb01004.x Yoon, 2007, Poster 32: Use of propranolol for treating tacrolimus-induced tremors: A case report, Arch Phys Med Rehabil, 88, 10.1016/j.apmr.2007.06.540 Lestner, 2010, Tremor: A newly described adverse event with long-term itraconazole therapy, J Neurol Neurosurg Psychiatry, 81, 327, 10.1136/jnnp.2009.174706 Bulkowstein, 2003, Ketoconazole-induced neurologic sequelae, Vet Hum Toxicol, 45, 239 Dietrich, 2008, Complications of cancer therapy, 300 Savica, 2011, Ifosfamide associated myoclonus-encephalopathy syndrome, J Neurol, 258, 1729, 10.1007/s00415-011-5990-4 Mena, 2006, Drug-induced parkinsonism, Expert Opin Drug Saf, 5, 759, 10.1517/14740338.5.6.759 Mutch, 1986, Parkinson’s disease in a Scottish city, Br Med J, 292, 534, 10.1136/bmj.292.6519.534 Marsden, 1980, The pathophysiology of extrapyramidal side-effects of neuroleptic drugs, Psychol Med, 10, 55, 10.1017/S003329170003960X Miller, 1974, Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism, Nature, 248, 596, 10.1038/248596a0 Donaldson, 2012, Marsden’s Book of Movement Disorders, Oxford Medicine Online, 555 Ayd, 1961, A survey of drug-induced extrapyramidal reactions, J Am Med Assoc, 175, 1054, 10.1001/jama.1961.03040120016004 Bertler, 1961, Effect of reserpine on the storage of new-formed catecholamines in the adrenal medulla, Acta Physiol Scand, 52, 44, 10.1111/j.1748-1716.1961.tb02198.x Jankovic, 1982, Treatment of hyperkinetic movement disorders with tetrabenazine: A double-blind crossover study, Ann Neurol, 11, 41, 10.1002/ana.410110108 Lieberman, 1985, Reversible parkinsonism related to meperidine, N Engl J Med, 132, 509 Hammerstad, 1986, Buspirone in Parkinson’s disease, Clin Neuropharmacol, 9, 556, 10.1097/00002826-198612000-00007 Leo, 1986, Movement disorders associated with the serotonin selective reuptake inhibitors, J Clin Psychiatry, 57, 449, 10.4088/JCP.v57n1002 Miguel, 2014, Iatrogenic parkinsonism: The role of flunarizine and cinnarazine, J Parkinsons Dis, 4, 645, 10.3233/JPD-140414 Indo, 1982, Metoclopramide-induced parkinsonism, Arch Neurol, 39, 494, 10.1001/archneur.1982.00510200036006 Sullivan, 2000, Parkinsonism after correction of hyponatremia with radiological central pontine myelinolysis and changes in the basal ganglia, J Clin Neurosci, 7, 256, 10.1054/jocn.1999.0192 May, 1993, Contrast agent overdose causing brain retention of contrast, seizures, and parkinsonism, Neurology, 43, 836, 10.1212/WNL.43.4.836